Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/5/26 20:19 | 6/4/26 | PSNL | Health | Health | Medical Laboratories | Tachibana Aaron | CA | O | CFO,COO | 4 | M.d | 1,651 | 10.48 | 0 | 158 | 382 | 199 | D | ||||||||||||||
6/5/26 20:19 | 6/4/26 | PSNL | Health | Health | Medical Laboratories | Tachibana Aaron | CA | O | CFO,COO | 4 | S.d | -1,651 | 10.48 | 0 | -158 | 199 | D | |||||||||||||||
5/29/26 20:45 | 5/28/26 | PSNL | Health | Health | Medical Laboratories | Hall Christopher M | CA | DO | CEO | 2 | M.dm | 1,263 | 6.32 | 0 | 200 | 556 | 236 | D | ||||||||||||||
5/29/26 20:45 | 5/28/26 | PSNL | Health | Health | Medical Laboratories | Hall Christopher M | CA | DO | CEO | 2 | S.dm | -1,263 | 6.32 | 0 | -200 | 236 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |